Barclays PLC Tela Bio, Inc. Transaction History

Barclays PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.39 - $6.36 $49,580 - $71,829	-11,294 Reduced 98.75%	143 $1,000
Q1 2024 May 15, 2024	SELL	$5.3 - $7.61 $57,414 - $82,439	-10,833 Reduced 48.64%	11,437 $65,000
Q4 2023 Feb 15, 2024	BUY	$4.5 - $7.51 $87,034 - $145,250	19,341 Added 660.33%	22,270 $147,000
Q3 2023 Nov 07, 2023	SELL	$7.85 - $10.68 $1,931 - $2,627	-246 Reduced 7.75%	2,929 $24,000
Q2 2023 Aug 03, 2023	BUY	$9.23 - $11.23 $29,305 - $35,655	3,175 New	3,175 $33,000

18.3M

759K

100

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $55.9M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.